Antifungals Global Market Report 2022- Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Antifungals Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, March 14, 2022 / EINPresswire.com/ – Antifungals industry trends include drug developers and manufacturers are scaling up the various departments such as research and development, marketing, and manufacturing through collaborations and strategic partnerships with other companies and research institutes, to expand the product portfolios. So, companies in the anti-infective drugs market should consider strategic collaborations to broaden their scope and product portfolios to increase the revenues and drive the antifungals market growth.

The global antifungals market size is expected to grow from $ 26.76 billion in 2021 to $ 30.94 billion in 2022 at a compound annual growth rate (CAGR) of 15.6%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global antifungals market share is then expected to reach $ 51.67 billion in 2026 at a CAGR of 13.7%.

Read more on the Global Antifungals Market Report:
https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

North America was the largest region in the drugs for antifungals market in 2021. The Middle East is expected to be the fastest growing region in the antifungal drugs market during the forecast period. The regions covered in the antifungal market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players covered in the global antifungals industry are Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories, Sanofi-Aventis, Kramer Laboratories, GlaxoSmithKline Gilead, Enzon Pharmaceuticals Inc. and Basilea Pharmaceutica AG.

TBRC’s global antifungals market report is segmented by drug type into echinocandins, azoles, polyenes, allylamines, end-user into hospitals and clinics, dermatology clinics, others, by route of administration into oral, parenteral, topical, by therapeutic indication into aspergillosis, dermatophytosis , candidiasis, others.

Antifungals Global Market Report 2022 – By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines), By End users (Hospitals & Clinics, Dermatology clinics, Other Users), By Route of Administration (Oral, Parenteral, Topical), By Therapeutic Indications ( Aspergillosis, Dermatophytosis, Candidiasis, Others) – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides a antifungals market overview, forecast antifungals market size and growth for the whole market , antifungals market segments, geographies, antifungals market trends, antifungals market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request for a Sample of the Global Antifungals Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp

Not what you were looking for? Here is a list of similar reports by The Business Research Company:

Anti-Viral Drug Therapy Market – By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies – Global Anti-Viral Drug Therapy Market Forecast To 2030
https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Antiemetics And Antinauseants Global Market Report 2022 – By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Others), By Application (Chemotherapy, Motion sickness , Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Others), By End Users (Hospital, Medical Center, Clinic, Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies / Drug Stores, Others), By Route Of Administration (Oral, Parenteral , Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report

Know More About The Business Research Company?
The Business Research Company is a market research and intelligence firms that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88 972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Market Research Products, Services, Solutions For Your Business – TBRC

.

By admin

Leave a Reply

Your email address will not be published.